price oct usd
hold rate reect skeptic compani
attain sale growth margin target compani beat
consensu organ growth estim miss margin expans
mix implic thesi reduc price target reect
lower estim rel lower peer group multipl
thing like
segment underli market remain healthi discoveri
dbe highlight robust biopharma drug discoveri market
contribut high singl digit growth life scienc side
growth food drove mid singl digit growth appli onesourc lab
servic remain strong qtr diagnost segment report
organ growth vs dbe driven high teen growth core
immunodiagnost doubl digit appli genom euroimmun
report healthi growth ytd expect grow
larg custom order
asia growth remain robust china india remain key compani
growth qtr drive double-digit growth apac region
america grew high-singl digit europ deceler low-singl
digit deceler europ larg due tough y/i comp
region drought drove declin food test
thing cautiou
miss ep target though beat ex-fx unusu incent
comp charg adjust ep miss prior guidanc
consensu estim dbe street larg due fx well
stock compens impact strong stock perform
qtr exclud fx impact incent comp impact ep
would markedli estim compani lower
full-year ep target result item though
rais organ growth guidanc
vanadi approv progress slower compani expect
believ receiv ce-ivd approv vanadi nipt system
soon highlight see softwar compon hold
distribut gmt
deutsch bank seek busi compani cover research report thu investor
awar rm may conict interest could aect object report investor consid
report singl factor make invest decis disclosur analyst certif
regulatori approv process manag note remain
track instal system lab year
forecast ratio
period end expens expens incom incom continu ep dilut con share share sale ex amort acquir cash flowoper cash cash revenu ep incl
period end asset equival st receiv current discontinu current equip secur asset asset asset discontinu liabil short-term liabil discontinu op current debt less current long-term liabil stockhold novemb
price current end previou trade session unless otherwis indic sourc local exchang via reuter bloomberg vendor
inform sourc deutsch bank subject compani sourc disclosur pertain recommend estim made secur
primari subject research pleas see recent publish compani report visit global disclosur look-up page websit http //research db com/
research/disclosures/companysearch asid within report import risk conict disclosur also found http //research db com/research/topics/equ
investor strongli encourag review inform invest
import disclosur requir regul
disclosur mark asterisk may also requir least one jurisdict addit unit state see
import disclosur requir non-u regul explanatori note
deutsch bank and/or aliat receiv non-invest bank relat compens
compani within past year
compani client deutsch bank secur inc within past year time
import disclosur requir non-u regul
